Tenders/2026/0159 - Invitation to submit proposals under framework agreements 961/2024 - Diverse Medicines, 2025/1627 - Cardiovascular System Medicines, 900/2024 - Antiretroviral Medicines for the treatment of HIV infection, 899/2024 - Respiratory System Medicines, 780/2024 – Musculoskeletal System Medicines, used in the treatment of endocrine diseases and hormones
Awarded🇵🇹PortugalSupplies

2026/0159 - Invitation to submit proposals under framework agreements 961/2024 - Diverse Medicines, 2025/1627 - Cardiovascular System Medicines, 900/2024 - Antiretroviral Medicines for the treatment of HIV infection, 899/2024 - Respiratory System Medicines, 780/2024 – Musculoskeletal System Medicines, used in the treatment of endocrine diseases and hormones

Auto-translated from Portuguese
Original title: 2026/0159 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 961/2024 - Medicamentos Diversos, 2025/1627 - Medicamentos do aparelho cardiovascular, 900/2024 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH, 899/2024 - Medicamentos do Aparelho Respiratório, 780/2024 –Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas, 491/2023 - Medicamentos do foro oncológico e imunomoduladores, 492/2023 - Medicamentos anti-infecios
Unidade Local de Saúde de Santa Maria, E. P. E.
Published: Mar 6, 2026
Updated: Aug 9, 2026
Source: Portal BASE (Portugal)

About This Opportunity

Translated

This tender, identified by reference 2026/0159, is an invitation for proposals under several existing framework agreements. These agreements cover a broad spectrum of pharmaceutical products essential for public health services. Specifically, the framework agreements include 961/2024 for Miscellaneous Medicines, 2025/1627 for Cardiovascular System Medicines, and 900/2024 for Antiretroviral Medicines crucial for the treatment of HIV infection. Additionally, the scope encompasses 899/2024 for Respiratory System Medicines, 780/2024 for Musculoskeletal System Medicines, which also extends to treatments for endocrine diseases and hormone-related conditions. Further categories include 491/2023 for Oncological Medicines and Immunomodulators, and 492/2023 for Anti-infective Medicines. The purpose of this invitation is to solicit proposals from eligible suppliers to provide these essential medicines, likely to meet ongoing or anticipated demand within the public sector. Potential bidders are expected to adhere to the terms and conditions stipulated within the referenced framework agreements. This procurement aims to ensure the continuous availability of a diverse range of high-quality pharmaceuticals, supporting various therapeutic areas and patient needs. Further details regarding specific quantities, delivery schedules, and evaluation criteria will be provided to interested parties who express their intent to participate.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 9,447.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Portuguese

This tender opportunity, identified as 2026/0159, invites proposals for the supply of diverse medicinal products under existing framework agreements. The procurement is being conducted by a contracting authority in Portugal, with information centralized via the Portal BASE, which covers public contracts across mainland Portugal and its autonomous regions.

This invitation falls within the scope of framework agreements 961/2024 for Diverse Medicines, 2025/1627 for Cardiovascular System Medicines, and 900/2024 for Antiretroviral Medicines.

The objective is to secure a reliable and competitive supply chain for a range of pharmaceutical products essential for public health services. Suppliers are expected to demonstrate their capacity to meet the specific requirements outlined within the referenced framework agreements. Typical requirements for such tenders often include adherence to stringent quality control standards, compliance with national and international pharmaceutical regulations, robust supply chain management capabilities, and the ability to provide timely deliveries. Interested parties should review the detailed specifications and terms of reference associated with each framework agreement to understand the precise product lists, quantities, delivery schedules, and contractual obligations.

This procurement is crucial for ensuring the continued availability of vital medications within Portugal's healthcare system.

Data provenance

This notice is sourced from base_gov_pt and was originally published on March 6, 2026. Last refreshed 100 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Unidade Local de Saúde de Santa Maria, E. P. E.

Unidade Local de Saúde de Santa Maria, E. P. E. has issued 1,415 procurement notices on BidsFactory, including 0 currently open and 1,386 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: October 15, 2026.

Frequently asked questions about this tender

What is the estimated budget?

The estimated contract value is Up to €9,447. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to GLAXOSMITHKLINE - PROD. FARMACEUTICOS. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Unidade Local de Saúde de Santa Maria, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Estimated Budget
Up to €9,447
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Portuguese

Source

base_gov_pt
Portal BASE (Portugal)
Public Procurement

Contracting Authority

Unidade Local de Saúde de Santa Maria, E. P. E.
🇵🇹Portugal